Francesco Cappelli

5.7k total citations
143 papers, 1.9k citations indexed

About

Francesco Cappelli is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Francesco Cappelli has authored 143 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 78 papers in Cardiology and Cardiovascular Medicine and 46 papers in Nephrology. Recurrent topics in Francesco Cappelli's work include Amyloidosis: Diagnosis, Treatment, Outcomes (85 papers), Parathyroid Disorders and Treatments (45 papers) and Cardiomyopathy and Myosin Studies (36 papers). Francesco Cappelli is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (85 papers), Parathyroid Disorders and Treatments (45 papers) and Cardiomyopathy and Myosin Studies (36 papers). Francesco Cappelli collaborates with scholars based in Italy, United States and Spain. Francesco Cappelli's co-authors include Federico Perfetto, Stefano Perlini, Luigi Padeletti, Maria Cristina Porciani, Carlo Di Mario, Claudio Rapezzi, Raffaele Martone, Franco Bergesio, Mattia Zampieri and Iacopo Olivotto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Francesco Cappelli

127 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Cappelli Italy 25 1.3k 766 608 307 220 143 1.9k
Wibke Reinhard Germany 17 366 0.3× 483 0.6× 120 0.2× 69 0.2× 83 0.4× 37 975
Colin Davenport Ireland 17 273 0.2× 98 0.1× 82 0.1× 102 0.3× 113 0.5× 49 837
Magda R. Hamczyk Spain 12 395 0.3× 135 0.2× 56 0.1× 77 0.3× 140 0.6× 22 811
Harish K. Datta United Kingdom 18 514 0.4× 32 0.0× 68 0.1× 248 0.8× 261 1.2× 45 1.4k
Eric Olinger Switzerland 18 456 0.4× 51 0.1× 397 0.7× 19 0.1× 90 0.4× 43 1.1k
Masayuki Ishihara Japan 10 247 0.2× 80 0.1× 230 0.4× 69 0.2× 45 0.2× 32 696
George Z. Fadda United States 18 381 0.3× 36 0.0× 300 0.5× 85 0.3× 157 0.7× 51 932
Jun-Ya Kaimori Japan 15 219 0.2× 58 0.1× 329 0.5× 33 0.1× 46 0.2× 41 775
Cong-Lin Liu United States 15 247 0.2× 110 0.1× 19 0.0× 59 0.2× 201 0.9× 21 913
Joachim Kreuder Germany 19 508 0.4× 185 0.2× 12 0.0× 71 0.2× 105 0.5× 53 1.4k

Countries citing papers authored by Francesco Cappelli

Since Specialization
Citations

This map shows the geographic impact of Francesco Cappelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Cappelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Cappelli more than expected).

Fields of papers citing papers by Francesco Cappelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Cappelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Cappelli. The network helps show where Francesco Cappelli may publish in the future.

Co-authorship network of co-authors of Francesco Cappelli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Cappelli. A scholar is included among the top collaborators of Francesco Cappelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Cappelli. Francesco Cappelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Zi Michael, Brian Claggett, Pablo García‐Pavía, et al.. (2025). Efficacy and Safety of Vutrisiran in Transthyretin Amyloid Cardiomyopathy Across the Age Spectrum: The HELIOS-B Trial. European Journal of Heart Failure. 27(12). 2971–2978.
2.
Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations
3.
Lillo, Rosa, Maria Chiara Meucci, Annamaria Del Franco, et al.. (2025). Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease. Journal of the American Heart Association. 14(11). e041627–e041627. 4 indexed citations
4.
Sinigiani, Giulio, Laura De Michieli, Aldostefano Porcari, et al.. (2024). Atrial Electro-functional Predictors of Incident Atrial Fibrillation in Cardiac Amyloidosis. Journal of Cardiovascular Magnetic Resonance. 26. 100354–100354.
5.
Limongelli, Giuseppe, Elena Biagini, Francesco Cappelli, et al.. (2024). The Italian Fabry Disease Cardiovascular Registry (IFDCR). European Heart Journal - Quality of Care and Clinical Outcomes. 10(6). 483–487. 4 indexed citations
6.
García‐Pavía, Pablo, Nicolas Piriou, Roberto Barriales‐Villa, et al.. (2024). Prevalence and Characteristics of Transthyretin Amyloid Cardiomyopathy in Hypertrophic Cardiomyopathy. ESC Heart Failure. 11(6). 4314–4324. 5 indexed citations
7.
Argirò, Alessia, Mattia Zampieri, Alberto Marchi, et al.. (2023). Approcci terapeutici nella cardiomiopatia ipertrofica: dal controllo dei sintomi alla terapia di precisione. Giornale italiano di cardiologia. 24(10). 792–799. 3 indexed citations
8.
Argirò, Alessia, Costanza Bürgisser, Francesco Fattirolli, et al.. (2023). Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients With Transthyretin Cardiac Amyloidosis. Canadian Journal of Cardiology. 40(3). 364–369. 3 indexed citations
9.
Smorti, Martina, Lucia Ponti, Alessia Argirò, et al.. (2023). Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. Frontiers in Psychology. 13. 1066224–1066224. 8 indexed citations
10.
Argirò, Alessia, Samuele Baldasseroni, Carlo Fumagalli, et al.. (2022). Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis. Internal and Emergency Medicine. 18(2). 585–593. 5 indexed citations
11.
Perfetto, Federico, Mattia Zampieri, Carlo Fumagalli, Marco Allinovi, & Francesco Cappelli. (2022). Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Internal and Emergency Medicine. 17(4). 957–969. 15 indexed citations
12.
Tassetti, Luigi, Carlo Fumagalli, Alessia Argirò, et al.. (2022). Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease. Journal of Cardiovascular Electrophysiology. 33(5). 1072–1078. 5 indexed citations
13.
Perfetto, Federico, Mattia Zampieri, Giulia Bandini, et al.. (2022). Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease. Biomedicines. 10(12). 3226–3226. 6 indexed citations
14.
Argirò, Alessia, Annamaria Del Franco, Marco Allinovi, et al.. (2022). Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not. Biomedicines. 10(11). 2888–2888. 9 indexed citations
15.
Emdin, Michele, Federico Perfetto, Alberto Aimo, et al.. (2021). Percorso clinico-assistenziale in rete per la diagnosi e la gestione del paziente con amiloidosi cardiaca. Documento di consenso ANMCO Toscana e SIC Tosco-Umbra. Giornale italiano di cardiologia. 22(8). 621–634.
16.
Argirò, Alessia, Mattia Zampieri, Martina Berteotti, et al.. (2021). Emerging Medical Treatment for Hypertrophic Cardiomyopathy. Journal of Clinical Medicine. 10(5). 951–951. 23 indexed citations
17.
Zampieri, Mattia, Marco Allinovi, Iacopo Olivotto, et al.. (2021). Ventricular tachyarrhythmias and sudden cardiac death in light‐chain amyloidosis: a clash of cardio‐toxicities?. British Journal of Haematology. 193(4). e27–e31. 5 indexed citations
18.
Fumagalli, Carlo, Mattia Zampieri, Federico Perfetto, et al.. (2021). Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis. Mayo Clinic Proceedings. 96(8). 2185–2191. 21 indexed citations
19.
Girolami, Francesca, Giuseppe Vergaro, Maurizio Pieroni, et al.. (2020). Percorso clinico proposto dall’ANMCO Toscana per la diagnosi genetica delle cardiomiopatie in un sistema assistenziale in rete. Giornale italiano di cardiologia. 21(12). 926–934. 2 indexed citations
20.
Cappelli, Francesco, Chiara Lazzeri, Gian Franco Gensini, & Serafina Valente. (2008). Cannabis: a trigger for acute myocardial infarction? A case report. Journal of Cardiovascular Medicine. 9(7). 725–728. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wibke Reinhard Breakdown of academic impact, for papers by Colin Davenport Breakdown of academic impact, for papers by Magda R. Hamczyk Breakdown of academic impact, for papers by Harish K. Datta Breakdown of academic impact, for papers by Eric Olinger Breakdown of academic impact, for papers by Masayuki Ishihara Breakdown of academic impact, for papers by George Z. Fadda Breakdown of academic impact, for papers by Jun-Ya Kaimori Breakdown of academic impact, for papers by Cong-Lin Liu Breakdown of academic impact, for papers by Joachim Kreuder
Rankless by CCL
2026